Is Intel Stock the Next Nvidia?

Why It Matters

Intel’s surge highlights the market’s appetite for AI‑related semiconductor exposure, but the stark profitability gap versus Nvidia suggests the stock may be overvalued and vulnerable to a correction.

Key Takeaways

• Intel Q1 revenue up 7% to $13.6 B, beating guidance.
• Data‑center AI revenue rose 22% YoY to $5.1 B.
• Intel stock surged ~500% YTD, near $130 per share.
• Nvidia still leads with $68.1 B quarterly revenue and 75% margin.
• Intel trades at ~140 forward P/E, far above Nvidia’s 24.

Pulse Analysis

The AI chip race has reshaped investor sentiment, and Intel’s recent rally underscores how quickly capital can flow into a legacy player that appears to be catching up. After reporting a 7% year‑over‑year revenue increase to $13.6 billion and a 22% surge in AI‑centric data‑center sales, the company secured a preliminary agreement to fabricate Apple chips and deepened collaborations with Nvidia, Tesla and Elon Musk’s Terafab venture. These strategic moves signal that Intel’s foundry and CPU platforms are gaining relevance in a market increasingly dominated by AI workloads, prompting a dramatic re‑rating of its stock.

However, the numbers tell a different story when Intel is measured against Nvidia, the sector’s benchmark. Nvidia posted a staggering $68.1 billion in quarterly revenue, with data‑center sales alone at $62.3 billion and a 75% gross margin—nearly double Intel’s 41% margin. While Intel’s AI segment is growing, its foundry unit posted a $2.4 billion operating loss and free cash flow turned negative, contrasting sharply with Nvidia’s $43 billion net income. The valuation gap is equally stark: Intel trades at a forward price‑to‑earnings multiple of roughly 140, versus Nvidia’s 24, suggesting the market may be pricing in future growth that is not yet evident.

For investors, the key question is whether Intel can translate its strategic partnerships into sustainable earnings momentum. The Apple manufacturing deal, Nvidia investment, and involvement in Terafab could accelerate capacity expansion and improve margins, but execution risk remains high amid heavy capital outlays. Until Intel demonstrates consistent free‑cash‑flow generation and narrows the profitability chasm, the stock’s lofty multiple may invite a pullback. Savvy investors might wait for a clearer earnings trajectory or a meaningful valuation correction before committing at current levels.